These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10117615)

  • 1. View mixed on new foray by Baxter.
    Wagner M
    Mod Healthc; 1992 May; 22(19):10. PubMed ID: 10117615
    [No Abstract]   [Full Text] [Related]  

  • 2. Caremark set to buy group, stalks another.
    Wagner M
    Mod Healthc; 1992 Sep; 22(36):3. PubMed ID: 10120352
    [No Abstract]   [Full Text] [Related]  

  • 3. Baxter initiatives aim to give growing non-hospital business more liberty to go its own way.
    Wagner M
    Mod Healthc; 1992 May; 22(18):6. PubMed ID: 10117610
    [No Abstract]   [Full Text] [Related]  

  • 4. Baxter split gets mixed reviews.
    Scott L
    Mod Healthc; 1995 Dec; 25(49):2-3. PubMed ID: 10152810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mega-merger, Baxter split stir up hospital-supply field.
    Scott L
    Mod Healthc; 1996 Jan; 26(2):26. PubMed ID: 10153950
    [No Abstract]   [Full Text] [Related]  

  • 6. A week of good news, bad news for Baxter.
    Wagner M
    Mod Healthc; 1992 Jan; 22(4):3. PubMed ID: 10115918
    [No Abstract]   [Full Text] [Related]  

  • 7. Premier renews pact with Baxter.
    Scott L
    Mod Healthc; 1994 Feb; 24(9):26. PubMed ID: 10131986
    [No Abstract]   [Full Text] [Related]  

  • 8. Calif. practice to decide on Caremark bid.
    Wagner M
    Mod Healthc; 1992 Sep; 22(39):22. PubMed ID: 10120597
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital-product suppliers mobilize.
    Wagner M
    Mod Healthc; 1991 Jan; 21(3):2. PubMed ID: 10108732
    [No Abstract]   [Full Text] [Related]  

  • 10. Baxter shakes industry with acquisition of Stuart.
    Werner C; Schooleman S
    Hosp Mater Manage; 1993 Jan; 18(1):1, 6-7. PubMed ID: 10123559
    [No Abstract]   [Full Text] [Related]  

  • 11. Baxter acquisition of Stuart division is off.
    Wagner M
    Mod Healthc; 1993 Mar; 23(9):3. PubMed ID: 10124248
    [No Abstract]   [Full Text] [Related]  

  • 12. 2 Baxter heads exit, restructuring continues.
    Scott L; Japsen B
    Mod Healthc; 1994 Jan; 24(1):3. PubMed ID: 10130657
    [No Abstract]   [Full Text] [Related]  

  • 13. U.S. companies competing for health business in Kuwait.
    Greene J; Nemes J
    Mod Healthc; 1991 Mar; 21(10):3. PubMed ID: 10109619
    [No Abstract]   [Full Text] [Related]  

  • 14. As layoffs hit, Baxter tools for growth.
    Wagner M
    Mod Healthc; 1990 Mar; 20(10):4. PubMed ID: 10103896
    [No Abstract]   [Full Text] [Related]  

  • 15. Baxter reports 9% rise in '95 profits.
    Moore JD
    Mod Healthc; 1996 Feb; 26(7):12. PubMed ID: 10154703
    [No Abstract]   [Full Text] [Related]  

  • 16. Baxter defines restructuring plans.
    Scott L
    Mod Healthc; 1993 Nov; 23(47):3. PubMed ID: 10129934
    [No Abstract]   [Full Text] [Related]  

  • 17. Big two's control of market to change supply industry.
    Scott L
    Mod Healthc; 1994 Feb; 24(9):45-6. PubMed ID: 10131997
    [No Abstract]   [Full Text] [Related]  

  • 18. Baxter takes charge, posts big loss.
    Scott L
    Mod Healthc; 1994 Jan; 24(5):14. PubMed ID: 10131366
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppliers endure large doses of change.
    Scott L
    Mod Healthc; 1996 Oct; 26(43):36-7. PubMed ID: 10162883
    [No Abstract]   [Full Text] [Related]  

  • 20. Baxter to divest urologicals and possibly other weak lines.
    Litsikas M
    Hosp Mater Manage; 1990 May; 15(5):1, 9. PubMed ID: 10104750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.